Merck Serono Co., Ltd.
Merck Serono Co., Ltd. is the Japanese arm of Merck Serono division and focuses on innovative pharmaceutical products in oncology, fertility and endocrinology.
In Japan, Merck Serono Co., Ltd. is an organization which mainly consists of Medical Department and two Business Units of Oncology and Reproductive Health/Metabolic Endocrinology.
| Facts & Figures | |
| Managing Director | Mark Smith, MD, MRCP (UK) |
| Number of employees | 300 |
| Therapeutic areas | Oncology, Fertility, Endocrinology and etc. |
| Major products | Erbitux®, Gonalef®, Saizen® |
